Dianthus Therapeutics (DNTH) Current Deferred Revenue (2022 - 2026)
Dianthus Therapeutics' Current Deferred Revenue was $1.19 million in Q4 2025, up 148.0% from $479,000 a year earlier and up 24.5% from the prior quarter.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Current Deferred Revenue (2022 - 2026) Analysis & Trends
From Q4 2022 onward, Dianthus Therapeutics has reported Current Deferred Revenue for 10 quarters.
- Current Deferred Revenue shows a three-year compound annual growth rate of 128.2% (FY2022 to FY2025).
- In earlier years, Current Deferred Revenue was $479,000 in FY2024 and $100,000 in FY2022.
- The Q4 2025 figure marks the highest quarterly Current Deferred Revenue in data going back to Q4 2022.
- Compared with a year earlier, Current Deferred Revenue has increased for four straight quarters, with growth averaging 352.0% over the last five quarters.
- Per Business Quant data, DNTH's Current Deferred Revenue in the three quarters before Q4 2025 was $954,000 (Q3 2025), $479,000 (Q2 2025) and $479,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Dianthus Therapeutics | 5.00 Bn | 4.95 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.59 Mn |
| Jun 30, 2026 | 1.52 Mn |
| Mar 31, 2026 | 1.49 Mn |
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | 954,000.00 |
| Jun 30, 2025 | 479,000.00 |
| Mar 31, 2025 | 479,000.00 |
| Dec 31, 2024 | 479,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
API Access
Dianthus Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=DNTH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "DNTH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=DNTH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();